- Ibandronate sodium
- Ibandronate sodium
- 13885-09-1Phosphine,[1,1'-biphenyl]-2-yldiphenyl-
- 13885-13-72-cyclopropyl-2-oxoacetic acid
- 138860-44-3Bio-catalyzer a?ár No. 11 (9CI)
- 138-86-3Cyclohexene,1-methyl-4-(1-methylethenyl)-
- 138865-23-31H-Pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione, 2,3-dihydro-, hydrate (1:2), (11aS)-
- 138872-44-32-Thiophenesulfonylchloride, 5-[(benzoylamino)methyl]-
- 138877-09-5(R,R,R)-2-Azabicyclo[3.3.0]octane-3-carboxylic Acid Benzyl Ester Hydrochloride Salt
- 138879-90-0D-Glucopyranoside, methyl, monododecanoate
- 138879-94-41,2-Ethanediaminium,N1,N2-bis[2-[bis(2-hydroxyethyl)methylammonio]ethyl]-N1,N2-bis(2-hydroxyethyl)-N1,N2-dimethyl-,chloride (1:4)
- 13888-77-2Benzene,1-(dimethylsilyl)-2,3,4,5,6-pentafluoro-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Ibandronate sodium |
EINECS | 682-157-0 |
| CAS No. | 138844-81-2 | Density | N/A |
| PSA | 160.98000 | LogP | 0.93820 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C9H22NNaO7P2 | Boiling Point | 587.8 °C at 760 mmHg |
| Molecular Weight | 355.24 | Flash Point | 309.3 °C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
Phosphonicacid, [1-hydroxy-3-(methylpentylamino)propylidene]bis-, monosodium salt (9CI);BM 21.0955;Bondronat;BM 21.0955Na;Ibandronatesodium;Bonviva;Boniva;Bondronate;hydrogène {1-hydroxy-3-[méthyl(pentyl)amino]-1-phosphonopropyl}phosphonate de sodium;Natriumhydrogen-{1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonat;Phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis-, monosodium salt;phosphonic acid, [1-hydroxy-3-(methylpentylamino)propylidene]bis-, monosodium salt;phosphonic acid, [1-hydroxy-3-(methylpentylamino)propylidene]bis-, sodium salt (1:1);sodium hydrogen {1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonate;Ibandronate Sodium Anhydrous; |
Article Data | 1 |
Ibandronate sodium Chemical Properties
Structure of Ibandronate sodium (CAS NO.138926-19-9):
.jpg)
IUPAC Name: sodium hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate hydrate
Empirical Formula: C9H24NNaO8P2
Molecular Weight: 359.2261
Melting Point: 84°C (dec)
Boiling Point: 587.8 °C at 760 mmHg
Flash Point: 309.3 °C
Enthalpy of Vaporization: 100.74 kJ/mol
Vapour Pressure: 2.88E-16 mmHg at 25°C
Physical Appearance: White Crystalline Powder
Product Categories: Bone resorption inhibitor;anti-osteoporosis;Intermediates & Fine Chemicals;Pharmaceuticals;API's;Ibandronate
Ibandronate sodium Uses
Inhibits bone resorption as a sodium salt and complexed with technetium Tc 99m for bone imaging. The monophosphonates are not active. Biphosphonates are used in disorders affecting the skeleton such as asteoporosis, metastatic disease, and Paget d.
Ibandronate sodium Safety Profile
Hazard Codes: 
Xn
Risk Statements: 40
R40:Limited evidence of a carcinogenic effect.
Safety Statements: 22-36
S22:Do not breathe dust.
S36:Wear suitable protective clothing.
Ibandronate sodium Specification
Ibandronate sodium , its cas register number is 138926-19-9. It also can be called Ibandronate sodium ; Sodium trihydrogen (1-hydroxy-3-
(methylpentylamino)propylidene)diphosphonate, monohydrate ; UNII-J12U072QL0 .
What can I do for you?
Get Best Price
